Renvela 800 mg sachets
46,92$
39,41$
Renvela 800 mg sachets are specifically designed for patients undergoing dialysis due to severe kidney disease, effectively managing elevated phosphorus levels in the blood. Although dialysis helps remove some phosphate, it often falls short of maintaining optimal balance, which is crucial for overall health. By lowering blood phosphate levels, Renvela contributes to stronger bones and mitigates the risk of harmful mineral accumulation that can lead to serious complications such as heart disease and stroke. This medication works by binding phosphorus in the gastrointestinal tract, preventing its absorption into the bloodstream. It’s essential for users to follow their healthcare provider’s instructions closely, as improper use may lead to unwanted side effects or interactions with other medications. Additionally, individuals with certain gastrointestinal disorders should exercise caution and consult their physician before starting Renvela. By incorporating this treatment into their care plan, patients can better manage their phosphorus levels and enhance their quality of life while on dialysis. Always prioritize regular monitoring and medical guidance to ensure safe and effective use of this phosphate binder.
Cantidad
Active Pharmaceutical Ingredient
Uses
• Renvela 800 mg sachets are primarily used to manage hyperphosphatemia, a condition characterized by elevated phosphorus levels in the blood. By helping to lower phosphorus absorption from food, this medication supports patients in maintaining healthier serum phosphate levels. This is particularly important for individuals undergoing dialysis or those with chronic kidney disease. Regular use of Renvela 800 mg sachets can contribute to better overall mineral balance.
• In patients with chronic kidney disease (CKD), Renvela 800 mg sachets play a crucial role in phosphate control. As kidney function declines, the ability to excrete phosphorus diminishes, leading to potential complications. Renvela 800 mg sachets help mitigate these risks by binding dietary phosphorus, thus reducing its levels in the bloodstream. This management is essential for preserving bone health and preventing cardiovascular issues associated with CKD.
• Healthcare providers often prescribe Renvela 800 mg sachets as part of a comprehensive treatment plan for patients with renal impairments. The medication aids in the dietary management of phosphorus, allowing patients to enjoy a wider variety of foods without excessive concern over phosphorus intake. By incorporating Renvela 800 mg sachets, individuals with kidney disease can achieve better metabolic control and enhance their quality of life. This approach is particularly beneficial for those on restricted diets due to their condition.
• Renvela 800 mg sachets are also utilized in the long-term care of patients with end-stage renal disease, particularly those receiving hemodialysis. The medication assists in managing phosphate levels effectively, which can otherwise lead to serious health complications. Using Renvela 800 mg sachets can help these patients maintain stable phosphorus levels, thus supporting their overall treatment goals. This proactive management is key to improving patient outcomes and promoting a healthier lifestyle.
Benefits
Renvela 800 mg efficiently reduces elevated levels of phosphate in the bloodstream, inhibits the buildup of excess phosphate in the body, promotes bone strength, and decreases the probability of heart disease and strokes. The primary function of Renvela Phosphate Binder is to bind in the gastrointestinal tract, leading to a decrease in its absorption. As a result, the overall concentration in the body is significantly lowered. The medication effectively manages hypophosphatemia, a condition characterized by elevated levels of phosphate in the blood. It is specifically designed for adults undergoing dialysis, whether it be hemodialysis or peritoneal dialysis, and also for patients with chronic kidney disease.
Side Effects
Renvela 800 mg Oral Powder may cause adverse effects. If any of these symptoms become severe or persist for a long time, consult your doctor.
Most Common Side Effects
• Headache
• Diarrhea
• Stomach upset
• Nausea
• Vomiting
• Cough
• Constipation
• Metabolic acidosis
Common Side Effects
• Trouble breathing
• Chest pain
• Allergic reaction
• Severe dizziness
How To Use
Renvela 800 mg sachets orally as directed by your doctor. Swallow the whole tablet whole. Do not crush, chew, or break the tablet into small pieces. Your doctor will determine your dose based on your medical condition. Tell your doctor or health care professional if you are taking any other medications to lower your phosphate levels.
Safety Advice
• Alcohol: It is strongly recommended that you do not drink alcohol while taking Renvela Sachets for CKD to avoid possible adverse effects.
• Kidney: Renvela 800 mg sachets is considered safe for patients with kidney disease. It is not necessary to adjust the dose of Renvela 800 mg. However, it is advisable to monitor calcium levels regularly in these patients.
• Breastfeeding: The safety of Sevelamer Carbonate Sachets in breastfeeding women has not been established. If you have any concerns about this, you should discuss them with your doctor. Your doctor will determine whether Renvela 800 mg can be given to breastfeeding mothers.
• Liver: Patients with liver impairment or liver disease should use Sevelamer Carbonate Sachets with caution. It is advisable to consult your doctor if you have any concerns or if you are experiencing liver impairment.
• Pregnancy: Renvela 800 mg sachets falls into the category of pregnancy medication classified as category C. It is recommended that you seek advice from your doctor if you have any concerns. Your doctor will only prescribe Renvela Sachets for CKD if the benefits outweigh the potential risks.
• Driving: Renvela 800 mg Oral Powder has no known effect on the ability to drive or operate machinery.